rapilysin
actavis group ptc ehf - reteplase - miokarda infarkts - antitrombotiskie līdzekļi - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.
telmisartan teva
teva b.v. - telmisartāns - hipertensija - agents, kas iedarbojas uz renīna-angiotenzīna sistēmu - esenciālas hipertensijas ārstēšana pieaugušajiem.
amlodipine sopharma 5 mg tabletes
sopharma ad, bulgaria - amlodipīns - tablete - 5 mg
amlodipine sopharma 10 mg tabletes
sopharma ad, bulgaria - amlodipīns - tablete - 10 mg
tenox 5 mg tabletes
krka, d.d., novo mesto, slovenia - amlodipīns - tablete - 5 mg
tenox 10 mg tabletes
krka, d.d., novo mesto, slovenia - amlodipīns - tablete - 10 mg
norvasc 5 mg tabletes
upjohn eesv, netherlands - amlodipīns - tablete - 5 mg
ramlon 2,5 mg/2,5 mg cietās kapsulas
egis pharmaceuticals plc, hungary - ramiprilum, amlodipinum - kapsula, cietā - 2,5 mg/2,5 mg
amlocard b 10 mg tabletes
hexal ag, germany - amlodipīns - tablete - 10 mg
amlocard b 5 mg tabletes
hexal ag, germany - amlodipīns - tablete - 5 mg